PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,271 stories, page 235 of 638

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Gridiron Backs the Back Office Behind Biotech

Private Equity ProfessionalOriginal source
🇺🇸Researchnews.nm.orgTier 2 · Direct publisher

Northwestern Medicine Expands Cardiovascular Services to Tinley Park

Northwestern MedicineOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Flipping the script on biology education, and scaling it up

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Guggenheim raises Amylyx stock price target on trial results By Investing.com

Investing.com South AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump Nominates White House Aide Dr. Heidi Overton to Lead Embattled FDA

streamlinefeed.co.keOriginal source
🇯🇵Researchriken.jpTier 2 · Direct publisher

Meet RIKEN's new laboratory heads (August 2026)

RIKENOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Fluidics enhances Solid Phase Extraction with new patented device

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Are Booming. What This Top Fund Is Buying Now.

Barron'sOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Nurses Need to Know About FDA-Approved Iberdomide in Multiple Myeloma

Oncology Nursing NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CTT Pharmaceutical (CTTH) CEO buys 10,000 more shares

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Shortage Leads to Nationwide Black Market

IranWireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Connor Broadley bought a biotech ETF for first time

CitywireOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Trump taps White House aide Heidi Overton as nominee for next FDA commissioner

Fierce BiotechOriginal source
🇨🇭CROpsi-cro.comTier 2 · Direct publisher

Placebo response in IBD trials

PSI CROOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Stock Price Today: Moderna Stock Rockets Higher After Positive Cancer Vaccine Trial – Here’s What Investors Should Know

The Sunday GuardianOriginal source
🇺🇰Researchmed.cam.ac.ukTier 2 · Direct publisher

Cambridge researchers develop new approach to study inflammatory lung diseases

University of Cambridge - Clinical Medicine NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

mRNA cancer vaccine trial win ripples across biotech and oncology stocks

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna and Merck Expose Groundbreaking mRNA Cancer Vaccine Efficacy in Phase 3

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 2 · Trade media

New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

QT9 Software updates for medical device, pharmaceutical and biotechnology teams

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI In Pharmacovigilance: The Commercial and Market-Access Imperative

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx (RARE) Stock Could Stay Fully Priced On Setrusumab Regulatory Talks

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cathay Biotech: Revenue and net profit surged on business expansion and new product lines, with robust R&D investment

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano

BioSpaceOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: In-silico Development- and Clinical-Trial-Platform for Testing in-situ Tissue Engineered Heart Valves

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Immune Niches for Cancer ImmunoTherapy Enhancement

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Ultra-fast Antimicrobial Susceptibility Test for diagnosing antimicrobial resistance to provide personalized antibiotic treatments

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Optoelectronic medicine - nerve cell regulation with light

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. Sanctions

Carnegie Endowment for International PeaceOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The biotech bi-weekly: NIH maternal health research prizes, a virtual human cell model and chondrocyte spheroids to treat joint degeneration

BioTechniquesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The New Frontier of Pharmaceutical Growth

Mexico Business NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GenBio Inc. Highlights Strategic Importance of Emerging Biotechnology Amid Expansion of U.S. Pharmaceutical Investment

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Shares Skyrocket Up to 90% as Its mRNA Cancer Vaccine With Merck Succeeds in Late-Stage Trial

International Business Times AustraliaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $5.00 by Analysts at HC Wainwright

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Surges Over 100% Pre-Market as Phase 3 Cancer Vaccine Trial With Merck Succeeds

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VRAX Stock Whipsaws As Traders Target Volatile Biotech Play

StocksToTradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

High Quality Undervalued Stocks Backed By Cash Flow In Japan

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biodexa's trial for a hereditary polyp condition passes halfway at 87 recruits

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ENCLONY Accelerates Global Expansion with Advanced Pharmaceutical Vision Inspection Technology

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jefferies Adjusts Genscript Biotech's Price Target to HK$30 From HK$15.50, Keeps at Buy

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BMO Capital Markets Initiates Coverage on BioMarin Pharmaceutical (NASDAQ:BMRN)

MarketBeatOriginal source
🇨🇭Industryinterpharma.chTier 1 · Company source

Medizinischer Fortschritt benötigt klinische Forschung

Interpharma SwitzerlandOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna, Merck's Personalized mRNA Cancer Vaccine Achieves First Late-Stage Trial Success

finance.biggo.comOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

StatStrip® Glucose And Beta-Ketone Hospital Meter

A software issue in StatStrip (Gen 2) Glucose and Beta-Ketone Hospital Meters may retain previous pa...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

SPECTRALIS® with Flex Module

There is a possibility that the castor wheels of the Flex stand are not properly attached. The wheel...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Embosphere® Microspheres-Syringe

Merit Medical Systems, Inc., on behalf of its subsidiary, Biosphere Medical, is voluntarily recallin...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A bioengineered vessel beat fistulas for women and men with obesity and diabetes on dialysis

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Personalized mRNA cancer vaccine succeeds in major phase 3 melanoma trial

JangOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sino Biopharmaceutical Launches Global Brand SBP Group; First-Half Overseas Licensing Deals Surpass $3.4 Billion

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma stock rating reiterated at Buy by H.C. Wainwright

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright cuts Oncolytics Biotech price target to $5 on pipeline shift

Investing.comOriginal source